Literature DB >> 7738117

Utrophin actin binding domain: analysis of actin binding and cellular targeting.

S J Winder1, L Hemmings, S K Maciver, S J Bolton, J M Tinsley, K E Davies, D R Critchley, J Kendrick-Jones.   

Abstract

Utrophin, or dystrophin-related protein, is an autosomal homologue of dystrophin. The protein is apparently ubiquitously expressed and in muscle tissues the expression is developmentally regulated. Since utrophin has a similar domain structure to dystrophin it has been suggested that it could substitute for dystrophin in dystrophic muscle. Like dystrophin, utrophin has been shown to be associated with a membrane-bound glycoprotein complex. Here we demonstrate that expressed regions of the predicted actin binding domain in the NH2 terminus of utrophin are able to bind to F-actin in vitro, but do not interact with G-actin. The utrophin actin binding domain was also able to associate with actin-containing structures, stress fibres and focal contacts, when microinjected into chick embryo fibroblasts. The expressed NH2-terminal 261 amino acid domain of utrophin has an affinity for skeletal F-action (Kd 19 +/- 2.8 microM), midway between that of the corresponding domains of alpha-actinin (Kd 4 microM) and dystrophin (Kd 44 microM). Moreover, this utrophin domain binds to non-muscle actin with a approximately 4-fold higher affinity than to skeletal muscle actin. These data (together with those of Matsumura et al. (1992) Nature, 360, 588-591) demonstrate for the first time that utrophin is capable of performing a functionally equivalent role to that of dystrophin. The NH2 terminus of utrophin binds to actin and the COOH terminus binds to the membrane associated glycoprotein complex, thus in non-muscle and developing muscle utrophin performs the same predicted 'spacer' or 'shock absorber' role as dystrophin in mature muscle tissues. These data suggest that utrophin could replace dystrophin functionally in dystrophic muscle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7738117     DOI: 10.1242/jcs.108.1.63

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  62 in total

1.  Binding of dystrophin's tandem calponin homology domain to F-actin is modulated by actin's structure.

Authors:  A Orlova; I N Rybakova; E Prochniewicz; D D Thomas; J M Ervasti; E H Egelman
Journal:  Biophys J       Date:  2001-04       Impact factor: 4.033

2.  Direct interaction of beta-dystroglycan with F-actin.

Authors:  Yun-Ju Chen; Heather J Spence; Jacqueline M Cameron; Thomas Jess; Jane L Ilsley; Steven J Winder
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

Review 3.  An open or closed case for the conformation of calponin homology domains on F-actin?

Authors:  William Lehman; Roger Craig; John Kendrick-Jones; Andrew J Sutherland-Smith
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

4.  Sparing of the extraocular muscles in mdx mice with absent or reduced utrophin expression: A life span analysis.

Authors:  Abby A McDonald; Sadie L Hebert; Linda K McLoon
Journal:  Neuromuscul Disord       Date:  2015-09-06       Impact factor: 4.296

5.  The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membrane.

Authors:  Armelle Bonet-Kerrache; Mathieu Fortier; Franck Comunale; Cécile Gauthier-Rouvière
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

6.  Solution structure of calponin homology domain of Human MICAL-1.

Authors:  Hongbin Sun; Haiming Dai; Jiahai Zhang; Xianju Jin; Shangmin Xiong; Jian Xu; Jihui Wu; Yunyu Shi
Journal:  J Biomol NMR       Date:  2006-10-17       Impact factor: 2.835

7.  The actin binding domain of ACF7 binds directly to the tetratricopeptide repeat domains of rapsyn.

Authors:  C Antolik; D H Catino; A M O'Neill; W G Resneck; J A Ursitti; R J Bloch
Journal:  Neuroscience       Date:  2007-01-10       Impact factor: 3.590

Review 8.  Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Authors:  Jane T Seto; Julian N Ramos; Lindsey Muir; Jeffrey S Chamberlain; Guy L Odom
Journal:  Curr Gene Ther       Date:  2012-06       Impact factor: 4.391

9.  Versatile fluorescent probes for actin filaments based on the actin-binding domain of utrophin.

Authors:  Brian M Burkel; George von Dassow; William M Bement
Journal:  Cell Motil Cytoskeleton       Date:  2007-11

10.  Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.

Authors:  Christine Péladeau; Aatika Ahmed; Adel Amirouche; Tara E Crawford Parks; Lucas M Bronicki; Vladimir Ljubicic; Jean-Marc Renaud; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2015-10-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.